logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
21/08/2025
The main contract for the Shanghai Stock Exchange 50 Index Futures rose more than 1% intraday, now at 2870.0 points.
Latest
3 m ago
Jiangjian Group: Net profit in the first half of 2025 increased by 48.66% year-on-year.
3 m ago
Fokker: Net profit of 230 million yuan in the first half of 2025, a year-on-year decrease of 32.54%
3 m ago
Cui Dongshu: In recent years, China's automobile exports have performed excellently and are expected to maintain a small monthly growth trend in 2025.
3 m ago
Market news: Imran Khan, the detained Pakistani leader, will not be released.
4 m ago
According to each AI news, on August 21st, Cinda Securities released a research report granting a buy rating to Wanfu Biotechnology (300482.SZ). The main reasons for the rating include: 1) the recovery of the toxicology business growth, while infectious disease and chronic disease testing are under pressure; 2) short-term profitability pressure, with long-term growth driven by innovation. (Daily Economic News)
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.